2-Methyl-6,7-dihydro-5h-pyrrolo[3,4-d]pyrimidine, 95%, 10g

2-Methyl-4-(2-thienyl)-1,3-thiazole, 95%, 10g

3-Hydroxy-4,5-dimethoxybenzaldehyde, 97.0%, 5g

Ethyl 4-(trifluoromethyl)-1H-indole-2-carboxylate, 95.0%, 100mg

Recipiente de cuello ancho, 120 ml, 100 Unidad(es)

1-(2-piridilazo)-2-naftol, mínimo 98 %, pa, ACS, 1 g, envase de vidrio

(1-Methyl-2-oxo-1,2-dihydropyridin-4-yl)boronic acid, 95.0%, 100mg

(5-Methoxypyridine-2-yl)methanol, 95.0%, 5g

1-Boc-Piperidine-2,4-dione, 97.0%, 5g

Matraces aforados clase A Vidrio transparente, 500 ml, 19/26, 2 unidad(es), 2 Pieza(s)

3-(Difluoromethoxy)piperidine hydrochloride, 98%, 500mg

Pyrrolidin-1-yl(pyrrolidin-3-yl)methanone, 98%, 2.5g

6-Bromo-1H-indol-3-yl acetate, 95.0%, 250mg